Status:
RECRUITING
Longitudinal Recovery Trajectories After an Acute Respiratory Distress Syndrome, a New Understanding
Lead Sponsor:
Institut de Recerca Biomèdica de Lleida
Collaborating Sponsors:
Instituto de Salud Carlos III
Conditions:
ARDS
ARDS Disease Progression
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 resulted in the largest cohort of critical illness survivors in history, heightened awareness of the importance of the respiratory sequelae after an acute distress respiratory syndrome (ADRS)...
Detailed Description
The coronavirus disease 2019 (COVID-19) resulted in the largest cohort of critical illness survivors in history, heightened awareness of the importance of the multi-dimensional sequelae after an acute...
Eligibility Criteria
Inclusion
- Male and female patients aged ≥18 years
- Admission to the ICU
- Diagnosis of severe pneumonia and/or diagnosis of acute respiratory distress syndrome (ARDS) based on the 2023 definition due to any origin (infectious and non-infectious)
Exclusion
- Life expectancy less than a year
- Transfer to another hospital during hospitalization or follow-up
- Stay in palliative care
- Severe mental disability that makes it impossible to carry out pulmonary function tests during follow-up
Key Trial Info
Start Date :
June 29 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT06083363
Start Date
June 29 2023
End Date
December 31 2026
Last Update
March 6 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Tortosa Verge de la Cinta
Tortosa, Tarragona, Spain, 43500
2
Hospital Universitari Arnau de Vilanova
Lleida, Spain, 25198
3
Hospital Universitari Joan XXIII
Tarragona, Spain, 43005